Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Inhibrx Biosciences (INBX) Return on Capital Employed: 2024-2025

Historic Return on Capital Employed for Inhibrx Biosciences (INBX) over the last 1 years, with Sep 2025 value amounting to -0.97%.

  • Inhibrx Biosciences' Return on Capital Employed rose 91.00% to -0.97% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.97%, marking a year-over-year increase of 91.00%. This contributed to the annual value of -1.63% for FY2024, which is N/A change from last year.
  • As of Q3 2025, Inhibrx Biosciences' Return on Capital Employed stood at -0.97%, which was down 9.43% from -0.89% recorded in Q2 2025.
  • Over the past 5 years, Inhibrx Biosciences' Return on Capital Employed peaked at -0.89% during Q2 2025, and registered a low of -2.06% during Q4 2024.
  • For the 2-year period, Inhibrx Biosciences' Return on Capital Employed averaged around -1.52%, with its median value being -1.79% (2025).
  • Data for Inhibrx Biosciences' Return on Capital Employed shows a peak YoY spiked of 91bps (in 2025) over the last 5 years.
  • Quarterly analysis of 2 years shows Inhibrx Biosciences' Return on Capital Employed stood at -2.06% in 2024, then surged by 91bps to -0.97% in 2025.
  • Its Return on Capital Employed stands at -0.97% for Q3 2025, versus -0.89% for Q2 2025 and -1.79% for Q1 2025.